Halotestin Halo Fluoxymesterone Anabolic Steroid Hormones Pharmaceutical Raw Materials CAS 76-43-7
Fluoxymesterone
Synonyms: 11-beta,17-beta-Dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one;17-alpha-methyl-9-alpha-fluoro-11-beta-hydroxytesterone;17-alpha-Methyl-9-alpha-fluoro-11-beta-hydroxytestosterone;9-alpha-fluoro-11-beta,17-beta-dihydroxy-17-alpha-methyl-4-androstene-3-one;9alpha-Fluoro-11beta,17beta-dihydroxy-17alpha-methyl-4-androstene-3-one;9-alpha-fluoro-11-beta-hydroxy-17-methyltestosterone;9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone;9-alpha-Fluoro-17-alpha-methyl-11-beta,17-dihydroxy-4-androsten-3-one
Product Categories: Organics;chiral;Steroids;Steroid and Hormone;Intermediates & Fine Chemicals;Pharmaceuticals;API;teroids
CAS: 76-43-7
Aliase:Halotestin
MF: C20H29FO3
MW: 336.44
EINECS: 200-961-8
mp : 240 °C
alpha : 104 o (c=1,EtOH)
solubility: H2O: ≤0.5 mg/mL
Purity:97.0~103.0%
form :solid (photosensitive)
color :white
Water Solubility : NEGLIGIBLE
Chemical Properties: white to light yellow crystal powde
Usage: Fluoxymesterone is an anabolic steroid with androgenic activity. Fluoxymesterone is used in the treatment of male hypogonadism. Fluoxymesterone showed antitumor effects on pregnancy-dependent mammary tumors TPDMT-4.
Usage: stimulates erythropoesis and cell respiration treatment of male hypogonadismdelayed puberty in males, managing metastatic breast cancer in menopausal women
Product description:
Fluoxymesterone (trade name Halotestin) is an anabolic steroid with strong androgenic properties that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. It is approximately 5 times as potent as methyltestosterone. The antitumor activity of fluoxymesterone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.
Applications:
Steroids Hormone Halotestin powders/Fluoxymesterone powders/CAS No: 1424-00-6
It is used to treat low testosterone levels in males and breast cancer in females.Though the half-life of fluoxymesterone is about 9.2 hours.
Permanent link: http://www.vvchem.com/sell/cas:76-43-7,3309042.html